A new i,i+7 amine-containing hydrocarbon staple — spanning two helical turns — significantly enhanced α-helical stability and proteolytic resistance of peptides, with a surprising finding that reversing the staple orientation dramatically improved helicity.
Orientation reversal dramatically enhanced helicityReversing the i,i+7 ACH staple orientation significantly improved α-helical stability beyond the canonical arrangement — a transferable design principle for stapled peptide therapeutics
What the researchers found
A 13-atom butylaminoalkenyl tether with SS configuration was identified as the most effective i,i+7 ACH staple. Orientation reversal substantially enhanced helicity and this effect transferred across helical registers. The optimized staple conferred significant proteolytic resistance, linking structural preorganization to biochemical resilience.
Why it matters
Expanding the ACH stapling toolkit to i,i+7 topology enables longer-range helical control for therapeutic peptides targeting protein-protein interactions, with improved aqueous compatibility over conventional staples.
The numbers in context
13-atom optimal tether length; SS stereochemistry; i,i+7 topology spanning 2 helical turns
How the study worked
Systematic variation of cross-link length, stereochemistry, and orientation in model peptides. Helicity measured by circular dichroism spectroscopy. Proteolytic resistance tested against enzymatic degradation. Transferability confirmed across different helical register positions.
What this study cannot tell us
This is a purely chemical study without biological activity data. The helicity measurements and proteolytic resistance were demonstrated in model peptides, not therapeutic candidates. Translation to specific disease-relevant peptides needs further validation. The study does not address cell permeability, in vivo stability, or pharmacokinetics of the stapled peptides.
How to read the evidence
This is a peptide chemistry study focused on conformational analysis and proteolytic stability. While the chemical findings are well-characterized, no biological activity or therapeutic efficacy data was presented.
When this study was published
Published in 2026, this study advances the cutting-edge field of peptide stapling chemistry, building on the growing clinical pipeline of stapled peptide drugs.
The bigger picture
Stapled peptides are one of the most commercially advanced peptide drug technologies, with several candidates in clinical trials. The original all-hydrocarbon (AHC) staples pioneered by the Verdine lab are hydrophobic and can limit water solubility. These amine-containing hydrocarbon (ACH) staples offer improved aqueous compatibility — critical for drug formulation — while maintaining the conformational lock that makes stapled peptides effective. Expanding from i,i+4 to i,i+7 provides longer-range structural control, enabling researchers to stabilize larger helical segments and potentially target protein-protein interactions that require extended helical surfaces.
Questions still open
- Do i,i+7 ACH-stapled peptides show improved cell permeability compared to conventional AHC staples?
- Can the orientation-reversal helicity enhancement be applied to therapeutic peptides targeting specific protein-protein interactions?
- How do ACH staples perform in vivo compared to all-hydrocarbon staples in terms of pharmacokinetics and efficacy?
Common questions
What is peptide stapling?
Why does spanning two helical turns matter?
Read the original research
Helix stabilization by i,i + 7 amine-containing hydrocarbon Staples: Effects of length, stereochemistry, and orientation.
Bioorganic & medicinal chemistry, 132, 118443
Citation
Nguyen, Ha T N; Lee, Su-Yeon; Tran, Duc V H; Kim, Young-Woo. (2026). Helix stabilization by i,i + 7 amine-containing hydrocarbon Staples: Effects of length, stereochemistry, and orientation.. Bioorganic & medicinal chemistry, 132, 118443. https://doi.org/10.1016/j.bmc.2025.118443